1) New study Tweetorial: Identifying patients with CKD risk at the time of nephrectomy: When to initiate nephrology consult in collaboration with @purvasharma821 @VBijol and Urology team with lead by Yihe Yang @JOncoNeph VA by @edgarvlermamd
2)The prevalence of CKD is high among kidney neoplasm patients because of the overlapping risk factors. Our purpose was to identify kidney cancer survivors with higher CKD risk.
3) Other recent papers that have looked at this are @AJKDonline ajkd.org/article/S0272-… and in @JASN_News jasn.asnjournals.org/content/29/1/2…
4)We recorded all nephrectomy specimens received at in last 2 years and retrospectively clinical data and labs. We also collected laboratory data at the time of and after the nephrectomy.
5)The non-neoplastic parenchyma was evaluated based on the best available representative section using Periodic acid-Schiff stain from which we recorded the estimated percent of GS, IFTA and and AAS.
6)Follow-up data, including SCr, BUN, eGFR, uric acid, HbA1c, serum albumin, and urinalysis, were collected at two follow-up time points: within 3 months (FU1) and more than 3 months (FU2) post nephrectomy.
7)Results: Our table 1 and table 2: Of patients with follow-up >3 months, 84% were identified retrospectively to fulfill criteria for CKD diagnosis, although CKD was documented in only 15%.
8)Results: Urinalysis was performed in sadly only 205 (57%) patients at the time of nephrectomy.
9)Results: Multivariate analysis IFTA >25%, severe arteriolar sclerosis, female , older age , BMI ⩾ 25, documented CKD, baseline eGFR ⩽ 60 and radical nephrectomy (p < 0.001) were independent risk factors of lower eGFR at baseline and during follow-up.
10)Results: Overall average eGFR by different: (a) overall average eGFR by sex, (b) overall average eGFR by age, (c) overall average eGFR by IFTA%, and (d) overall average eGFR by AAS.
11)Results: Kidney function at follow up:
Average eGFR decreased within 3 months post nephrectomy. However, patients with different risk levels showed different eGFR time trend pattern at longer follow-ups.
12)Results: Multivariate analysis of time × risk factor interaction showed BMI, radical nephrectomy and baseline eGFR had time-dependent impact. BMI ⩾ 25 kg/m2 and radical nephrectomy were associated with steeper eGFR decrease slope.
13)Results: In baseline eGFR > 90 ml/min/1.73 m2 group, eGFR rebounded to pre-nephrectomy levels during extended follow-up. In partial nephrectomy patients with baseline eGFR ⩾ 90 (n = 61), proteinuria and BMI were independent risk factors of decreased eGFR during follow up.
14)Results: In the 127 patients with ⩾3 months follow-up, 107 patients (84.3%) were identified retrospectively to fulfill criteria for CKD diagnosis. Only 16 (15.0%) of them had documented CKD diagnosis in EMR system.
15)Results: Two patients (1.9%) were at CKD stage 1; 25 patients (23.4%) were at CKD stage 2; 55 patients (50.5%) were at CKD stage 3; 15 patients (14.0%) were at CKD stage 4; 11 patients (10.2%) were at CKD stage 5.
16)Results: Denovo CKD: 23 patients fulfill the following criteria: (1) no history of CKD prior to nephrectomy; (2) eGFR ⩾ 90 (3) negative proteinuria at nephrectomy. Eleven (47.8%) of these patients had follow-up >3 months. These patients showed acute eGFR decrease at 3m
17)Limitations: Retrospective nature of our study. These patient had limited follow up, with post-nephrectomy eGFR measurements at >3 months available in a minority of patients. Third, as this was a single institution study, findings may lack generalizability.
18)Conclusions: A minimum workup for all patients undergoing nephrectomy must include SCr, eGFR, and urinalysis; this seemingly universal standard of care has not been always followed in practice in a large proportion of patients in our experience.
19)We confirm that non-neoplastic renal pathology evaluation is of great value and should include an estimate of % GS and IFTA. Patients with any proteinuria and/or eGFR ⩽ 60 at the time of nephrectomy or in follow-up, and/or >25% GS or IFTA, should be referred to nephrology
20) end tweetorial @threaderapp @UnrollHelper compile please

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Kenar Jhaveri

Kenar Jhaveri Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kdjhaveri

22 Jun
Short Tweetorial from my talk on Membranous Nephropathy: 2021 Update: #glomerular disease
1. Three types of Membranous- Primary, Secondary and Allo-immune
2. Causes of secondary MN: Cancers, Drugs, Infections and autoimmune disease( like any other disease).
3. Class switching happens: be-aware
Read 24 tweets
28 May
SLGT2i and the Kidney Tweetorial Part 2
Start: Time to #flozinate
When prescribing- mindful for bp management kidney360.asnjournals.org/content/2/4/74… @aishaikh
What about Scrt... SGLT2i therapy can cause an acute drop in eGFR. In the absence of hemodynamic instability or an alternate cause of AKI, the initial decline in GFR by  4-8 ml/min/1.73m2 after SGLT2i initiation is likely due to reduction in intra-glomerular pressure.
A typical patient included in CREDENCE would lose 4.6 ml/min/year of eGFR if treated with RAASi only, reaching ESKD in 10 years. However, if canagliflozin is added to his treatment, he would only lose 1.85 ml/min/year of eGFR, delaying ESKD by 15 kidney360.asnjournals.org/content/early/…
Read 12 tweets
28 May
Post Grand Rounds SLGT2i and the Kidney Tweetorial
- The Glucoretics - thanks @edgarvlermamd @ChristosArgyrop @jam_hirsch for some slides
Start...PART 1 nature.com/articles/s4158…
SGLT2 is responsible for reabsorbing up to 90% (animal data) of the glucose filtered at the glomerulus. The remaining 10% (animal data) is reabsorbed by SGLT1 that is expressed on the luminal (brush border) surface of cells of the S3 segment of the proximal tubule
Pathophysiology of Diabetic Nephropathy and role of SGLT2
Read 26 tweets
9 Dec 20
1. Here is short tweet summary of our analysis of myeloma patients on dialysis that received a renal transplant and their outcomes @NDTsocial @vinaynairdo @renalmyeloma @DrMHB1 @MersemaA academic.oup.com/ndt/advance-ar…
2. Most data regarding outcomes of kidney transplantation in patients with myeloma come from single center case series. With the advent of novel treatment choices, it remains unclear if outcomes of kidney transplant recipients with myeloma have improved in last decade
3.Literature reviews for multiple myeloma or smoldering MM with kidney transplantation were performed. Case series with at least one kidney transplant recipient with a history of multiple myeloma were included.
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(